PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys (original) (raw)

• Neuroscience of Psychoactive Substance Use and Dependence. (World Health Organization, Geneva, Switzerland, 2004).
• 2003 National Survey on Drug Use and Health (NSDUH). (US Department of Health and Human Services, National Institute on Drug Abuse, Rockville, Maryland, 2004).
• O'Brien, M.S. & Anthony, J.C. Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000–2001. Neuropsychopharmacology 30, 1006–1018 (2005).
  Article Google Scholar
• Emergency Department Trends From The Drug Abuse Warning Network: Final Estimates 1994–2001. (US Department of Health and Human Services, National Institute on Drug Abuse, Rockville, Maryland, 2002).
• Mello, N.K. & Negus, S.S. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14, 375–424 (1996).
  Article CAS Google Scholar
• Leshner, A.I. Vulnerability to addiction: new research opportunities. Am. J. Med. Genet. 96, 590–591 (2000).
  Article CAS Google Scholar
• Leshner, A.I. Addiction is a brain disease, and it matters. Science 278, 45–47 (1997).
  Article CAS Google Scholar
• Griffith, R.R., Bigelow, G.E. & Henningfield, J.E. Similarities in animal and human drug-taking behavior. in Advances in Substance Abuse Vol. 1 (ed. Mello, N.K.) 1–90 (JAI Press, Greenwich, Connecticut, 1980).
  Google Scholar
• Spealman, R.D. & Goldberg, S.R. Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu. Rev. Pharmacol. Toxicol. 18, 313–339 (1978).
  Article CAS Google Scholar
• Woolverton, W.L. & Nader, M.A. Experimental evaluation of the reinforcing effects of drugs. in Testing and Evaluation of Drugs of Abuse (eds. Adler, M.W. & Cowan, A.) 165–192 (Wiley-Liss, New York, 1990).
  Google Scholar
• Reith, M.E., Sershen, H. & Lajtha, A. Saturable [3H]cocaine binding in central nervous system of mouse. Life Sci. 27, 1055–1062 (1980).
  Article CAS Google Scholar
• Madras, B.K., Fahey, M.A., Bergman, J., Canfield, D.R. & Spealman, R.D. Effects of cocaine and related drugs in nonhuman primates, I: [3H]cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251, 131–141 (1989).
  CAS PubMed Google Scholar
• Blum, K., Cull, J.C., Braverman, E.R. & Comings, D.E. Reward deficiency syndrome. Am. Sci. 84, 132–145 (1996).
  Google Scholar
• Nader, M.A. & Czoty, P.W. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am. J. Psychiatry 162, 1473–1482 (2005).
  Article Google Scholar
• Volkow, N.D. et al. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am. J. Psychiatry 156, 1440–1443 (1999).
  Article CAS Google Scholar
• Morgan, D. et al. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat. Neurosci. 5, 169–174 (2002).
  Article CAS Google Scholar
• Volkow, N.D. et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14, 169–177 (1993).
  Article CAS Google Scholar
• Martinez, D. et al. Cocaine dependence and D2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 29, 1190–1202 (2004).
  Article CAS Google Scholar
• Dackis, C. & O'Brien, C. Neurobiology of addiction: treatment and public policy ramifications. Nat. Neurosci. 8, 1431–1436 (2005).
  Article CAS Google Scholar
• Mach, R.H. et al. Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptor: in vitro binding studies and positron emission tomography. Synapse 24, 322–333 (1996).
  Article CAS Google Scholar
• Mach, R.H. et al. Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release. Pharmacol. Biochem. Behav. 57, 477–486 (1997).
  Article CAS Google Scholar
• Dewey, S.L. et al. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J. Neurosci. 12, 3773–3780 (1992).
  Article CAS Google Scholar
• Nader, M.A. et al. PET imaging of dopamine D2 receptors with [18F] fluoroclebopride in monkeys: effects of isoflurane- and ketamine-induced anesthesia. Neuropsychopharmacology 21, 589–596 (1999).
  Article CAS Google Scholar
• Logan, J. et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 10, 740–747 (1990).
  Article CAS Google Scholar
• Hietala, J., Kuoppamaki, M., Nagren, K., Lehikoinen, P. & Syvalahti, E. Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man – a positron emission tomography study. Psychopharmacology (Berl.) 132, 361–365 (1997).
  Article CAS Google Scholar
• Zernig, G., Wakonigg, G., Madlung, E., Haring, C. & Saria, A. Do vertical shifts in dose-response rate-relationships in operant conditioning procedures indicate “sensitization” to “drug wanting”? Psychopharmacology (Berl.) 171, 349–351 (2004).
  Article CAS Google Scholar
• Laruelle, M. et al. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 17, 162–174 (1997).
  Article CAS Google Scholar
• Kalivas, P.W. & Duffy, P. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol. Psychiatry 25, 913–928 (1989).
  Article CAS Google Scholar
• Piazza, P.V. & Le Moal, M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19, 67–74 (1998).
  Article CAS Google Scholar
• Goeders, N.E. Stress and cocaine addiction. J. Pharmacol. Exp. Ther. 301, 785–789 (2002).
  Article CAS Google Scholar
• Volkow, N.D. & Folwer, J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex 10, 318–325 (2000).
  Article CAS Google Scholar
• Bradberry, C.W. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J. Neurosci. 20, 7109–7115 (2000).
  Article CAS Google Scholar
• Moore, R., Vinsant, S.L., Nader, M.A., Porrino, L.J. & Friedman, D.P. Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse 30, 88–96 (1998).
  Article CAS Google Scholar
• Nader, M.A. et al. Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 27, 35–46 (2002).
  Article CAS Google Scholar
• Robinson, T.E. & Berridge, K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18, 247–291 (1993).
  Article CAS Google Scholar
• Piazza, P.V., Deminiere, J.-M., Le Moal, M. & Simon, H. Factors that predict individual vulnerability to amphetamine self-administration. Science 245, 1511–1513 (1989).
  Article CAS Google Scholar
• Koob, G.F. & Le Moal, M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 8, 1442–1444 (2005).
  Article CAS Google Scholar
• Grigson, P.S. & Twining, R.C. Cocaine-induced suppression of saccharin intake: a model of drug-induced devaluation of natural rewards. Behav. Neurosci. 116, 321–333 (2002).
  Article CAS Google Scholar
• Ahmed, S.H. & Koob, G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282, 298–300 (1998).
  Article CAS Google Scholar
• Calabresi, P., De Murtas, M. & Bernardi, G. The neostriatum beyond the motor function: experimental and clinical evidence. Neuroscience 78, 39–60 (1997).
  Article CAS Google Scholar
• Piazza, P.V., Deroche-Gamonent, V., Rouge-Pont, F. & Le Moal, M. Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J. Neurosci. 20, 4226–4232 (2000).
  Article CAS Google Scholar
• Volkow, N.D. et al. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am. J. Psychiatry 147, 719–724 (1990).
  Article CAS Google Scholar
• Czoty, P.W., Gage, H.D. & Nader, M.A. PET imaging of striatal dopamine D2 receptors in nonhuman primates: increases in availability produced by chronic raclopride treatment. Synapse 58, 215–219 (2005).
  Article CAS Google Scholar
• Dewey, S.L. et al. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15, 821–829 (1995).
  Article CAS Google Scholar
• Mach, R.H. et al. The use of [18F]4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis: model alkylation studies and its application in the design of dopamine D1 and D2 receptor-based imaging agents. Nucl. Med. Biol. 20, 777–794 (1993).
  Article CAS Google Scholar
• Mach, R.H. et al. 18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography. J. Med. Chem. 36, 3707–3720 (1993).
  Article CAS Google Scholar
• Mintun, M.A., Raichle, M.E., Kilbourn, M.R., Wooten, G.F. & Welch, M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 15, 217–227 (1984).
  Article CAS Google Scholar